Can modification of renal replacement therapy improve the outcome of patients with systemic inflammatory response syndrome?

Blood Purification

Volumn 24, Issue 3, 2006, Pages 317-318

  Davenport, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TOXIC SHOCK SYNDROME TOXIN 1;

ACUTE KIDNEY FAILURE; CLINICAL PRACTICE; EDITORIAL; HEMOFILTRATION; HUMAN; HYDROPHILICITY; MOLECULAR WEIGHT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 33744456759     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091850     Document Type: Editorial

References (10)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
2. Kellum J, Johnson J, Kramer D, Palevsky P, Brady JJ, Pinsky MR: Diffusive versus convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998;26:1995-2000.
3. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 1999;25:814-821.
4. Honore PM, Jamez J, Wauthier M, Lee PA, Dugemier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term high-volume isovolaemic haemofiltration on the haemodynamic course and outcome of patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
5. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous haemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomised trial. Crit Care Med 2002;30:2205-2211.
6. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M: Continuous haemofiltration/haemodiafiltration in critical care. Ther Apher 2002;6:193-198.
7. Sadamori H, Yaki T, Inagaki M, Shima Y, Matsuda H, Tanaka N, Sakaguchi K, Tsuji T, Matsumi M, Katayama H, Hirakawa N: High-flow-rate haemodiafiltration as a brain support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure. Eur J Gastroenterol Hepatol 2002;14:435-439.
8. Lee PA, Weger GW, Pryor RW, Matson JR: Effects of filter pore size on efficacy of continuous arteriovenous haemofiltration therapy for Staphylococcus aureus induced septicaemia in immature swine. Crit Care Med 1998;26:730-737.
9. Winchester JF, Kellum A, Ronco C, Brady JA, Quartararo PJ, Salsberg JA, Levin NW: Sorbents in acute renal failure and the systemic inflammatory system. Blood Purif 2003;21:79-84.
10. Miwa K, Fukuyama M, Matsuno N, Shimada K, Ikeda K, Ikeda T: Physiological response to superantigen-adsorbing hemoperfusion in toxin-concentration- controlled septic swine. Blood Purif 2006;24:319-326.